Effect of extensive debridement and treatment on the healing of diabetic foot ulcers

Journal of the American College of Surgeons

Volumn 183, Issue 1, 1996, Pages 61-64

  Steed, David L ^a,c   Donohoe, Dennis ^b   Webster, Marshall W ^a   Lindsley, Linda ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b Robert Wood Johnson P   (United States)

^c PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECAPLERMIN; PLATELET DERIVED GROWTH FACTOR BB; RECOMBINANT PLATELET DERIVED GROWTH FACTOR BB; UNCLASSIFIED DRUG;

ARTICLE; CALLUS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEBRIDEMENT; DIABETIC FOOT; DOUBLE BLIND PROCEDURE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; ULCER HEALING;

ANTICOAGULANTS; CHRONIC DISEASE; COMBINED MODALITY THERAPY; DEBRIDEMENT; DIABETIC FOOT; DOUBLE-BLIND METHOD; HUMANS; PLATELET-DERIVED GROWTH FACTOR; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; UNITED STATES; WOUND HEALING;

EID: 0030018167     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Steed, D. L., Goslen, J. B., Holloway, G. A., and others. Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. Diabetes Care, 1992, 15: 1598-1604.
2. Robson, M. C., Phillips, L. G., Thomason, A., and others. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. Lancet, 1992, 339: 23-25.
3. Mustoe, T. A., Cutler, N. R., Allman, R. M., and others. A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and 4 pressure ulcers. Arch. Surg., 1994, 129: 213-219.
4. Krupski, W. C., Reilly, L. M., Perez, S., and others. A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: a preliminary report. J. Vasc. Surg., 1991, 14: 526-536.
5. Steed, D. L., and the Diabetic Ulcer Study Group. Clinical evaluation of recombinant platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. J. Vasc. Surg., 1995, 21: 71-81.
6. Ziffren, S. E., Heist, M. A., May, S. C., and others. The secretion of collagenase by maggots and its implication. Ann. Surg., 1953, 138: 932-937.
7. Robinson, W., and Norwood, V. H. Destruction of pyogenic bacteria in the alimentary tract of surgical maggots implanted in infected wounds. J. Lab. Clin. Med., 1934, 19: 581-586.
8. Sinclair, R. D., and Ryan, T. J. Proteolytic enzymes in wound healing: the role of enzymatic debridement. Australas. J. Dermatol., 1994, 35: 35-41.
9. Boulton, A. J. M. B. Article on enzymatic debridement inspires literature search on controlled studies. Ostomy Wound Management, 1994, 40: 8 (letter).
10. Varghese, M. C., Balin, A. K., Carter, D. M., and Caldwell, D. Local environment of chronic wounds under synthetic dressings. Arch. Dermatol., 1986, 122: 52-57.
11. Robson, M. C., Stenberg, B. D., and Heggers, J. P. Wound healing alterations caused by infection. Clin. Plast. Surg., 1990, 17: 485-492.
12. Knighton, D. R., Ciresi, K., Fiegel, V. D., and others. Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. Surg. Gynecol. Obstet., 1990, 170: 56-60.